Market Tracker

10/20 5:16pm ET

Dynavax Technologies Corp (NASDAQ:DVAX)

20.40
Delayed Data
As of Oct 20
 -0.45 / -2.16%
Today’s Change
3.20
Today|||52-Week Range
24.45
+416.46%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close20.85
Today’s open20.95
Day’s range20.25 - 21.15
Volume787,295
Average volume (3 months)2,536,953
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+10.15%
Earnings growth (this year)+30.22%
Earnings growth (next 5 years)--
Revenue growth (last year)+172.67%
P/E ratioNM
Price/Sales13.77
Price/Book8.83

Competitors

 Today’s
change
Today’s
% change
CLLSCellectis SA+2.60+9.36%
XNCRXencor Inc-0.51-2.34%
DERMDermira Inc-0.13-0.45%
AIMTAimmune Therapeutics...-0.06-0.23%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$11.0M
Annual profit (last year)-$112.4M
Net profit margin-1,018.24%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts